| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Revenue | $2.67B | +23.3% |
| Cost of Revenue | $618.2M | +29.6% |
| Gross Profit | $2.05B | +21.5% |
| R&D Expense | $672.5M | +34.5% |
| SG&A Expense | $251.8M | +18.7% |
| Operating Income | -$128.5M | -5.7% |
| Interest Expense | $5.3M | +0.0% |
| Pre-tax Income | -$18.3M | +37.4% |
| Income Tax | $23.2M |
| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.39B | +67.9% |
| Accounts Receivable | $992.2M | +34.7% |
| Current Assets | $4.89B | +44.1% |
| Total Assets | $6.42B | +36.4% |
| Current Liabilities | $2.43B | -21.9% |
| Total Liabilities | $4.62B | +34.7% |
| Stockholders' Equity | $1.80B | +41.2% |
| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $972.5M | +24.7% |
| Capital Expenditures | $164.3M | +13.6% |
| Investing Cash Flow | -$427.0M | +37.5% |
| Financing Cash Flow | $420.5M | +554.9% |
| Free Cash Flow | $808.2M | +27.2% |
| -18.6% |
| Net Income | -$41.5M | +28.1% |
| EPS (Basic) | -$0.27 | +30.8% |
| EPS (Diluted) | -$0.27 | +30.8% |